CASTLE BIOSCIENCES ($CSTL) posted quarterly earnings results on Monday, May 5th. The company reported earnings of -$0.20 per share, missing estimates of -$0.07 by $0.13. The company also reported revenue of $87,990,000, beating estimates of $81,946,228 by $6,043,772.
You can see Quiver Quantitative's $CSTL stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
CASTLE BIOSCIENCES Insider Trading Activity
CASTLE BIOSCIENCES insiders have traded $CSTL stock on the open market 153 times in the past 6 months. Of those trades, 0 have been purchases and 153 have been sales.
Here’s a breakdown of recent trading of $CSTL stock by insiders over the last 6 months:
- DEREK J MAETZOLD (Pres. & Chief Exec. Officer) has made 0 purchases and 130 sales selling 101,587 shares for an estimated $2,639,325.
- DANIEL BRADBURY has made 0 purchases and 18 sales selling 23,601 shares for an estimated $694,555.
- FRANK STOKES (Chief Financial Officer) has made 0 purchases and 3 sales selling 14,969 shares for an estimated $422,045.
- TOBIN W JUVENAL (Chief Commercial Officer) has made 0 purchases and 2 sales selling 5,737 shares for an estimated $191,608.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
CASTLE BIOSCIENCES Hedge Fund Activity
We have seen 101 institutional investors add shares of CASTLE BIOSCIENCES stock to their portfolio, and 100 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- UBS GROUP AG added 758,466 shares (+1401.1%) to their portfolio in Q4 2024, for an estimated $20,213,118
- WELLINGTON MANAGEMENT GROUP LLP added 722,120 shares (+inf%) to their portfolio in Q4 2024, for an estimated $19,244,498
- BELLEVUE GROUP AG removed 516,048 shares (-40.9%) from their portfolio in Q4 2024, for an estimated $13,752,679
- PORTOLAN CAPITAL MANAGEMENT, LLC removed 479,049 shares (-38.2%) from their portfolio in Q4 2024, for an estimated $12,766,655
- SOLEUS CAPITAL MANAGEMENT, L.P. removed 409,415 shares (-61.8%) from their portfolio in Q4 2024, for an estimated $10,910,909
- MILLENNIUM MANAGEMENT LLC added 408,272 shares (+290.5%) to their portfolio in Q4 2024, for an estimated $10,880,448
- JACOBS LEVY EQUITY MANAGEMENT, INC removed 361,739 shares (-72.9%) from their portfolio in Q4 2024, for an estimated $9,640,344
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
CASTLE BIOSCIENCES Government Contracts
We have seen $20,000 of award payments to $CSTL over the last year.
Here are some of the awards which we have have seen pay out the most over the last year:
To track government contracts to publicy traded companies, check out Quiver Quantitative's government contracts dashboard.
CASTLE BIOSCIENCES Analyst Ratings
Wall Street analysts have issued reports on $CSTL in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Guggenheim issued a "Buy" rating on 03/28/2025
To track analyst ratings and price targets for CASTLE BIOSCIENCES, check out Quiver Quantitative's $CSTL forecast page.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
